Literature DB >> 16079929

Lack of association between carotid intima-media thickness and PAF-acetylhydrolase mass and activity in patients with primary hyperlipidemia.

Dimitrios N Kiortsis1, Sofia Tsouli, Evangelia S Lourida, Vasilios Xydis, Maria I Argyropoulou, Moses Elisaf, Alexandros D Tselepis.   

Abstract

Carotid intima media thickness (IMT), represents an important clinical indicator of early atherosclerosis. Human plasma platelet-activating factor acetylhydrolase (PAF-AH) is an enzyme primarily associated with low-density lipoprotein (LDL) while a small proportion of enzymatic activity is also associated with high-density lipoprotein (HDL). Plasma paraoxonase 1 (PON1) is an esterase exclusively associated with HDL. The authors investigated the possible relationship between carotid IMT and the plasma levels of PAF-AH mass and activity as well as the PON1 activity in hyperlipidemic patients. One hundred unrelated patients with primary hyperlipidemia and 67 age-and sex-matched normolipidemic apparently healthy volunteers participated in the study. The PAF-AH activity in total plasma and in HDL-rich plasma (HDL-PAF-AH activity), the plasma PAF-AH mass, and the serum PON1 activities toward paraoxon and phenyl acetate were determined. The plasma PAF-AH mass and activity were higher in hyperlipidemic patients compared to controls, whereas the HDL-PAF-AH activity, as well as the serum PON1 activities were not significantly different between the studied groups. When hyperlipidemic patients were divided into 2 subgroups according to their IMT values (IMT <0.7 mm and IMT > or =0.7 mm) patients with IMT > or =0.7 mm had significantly higher age, and serum triglyceride concentrations, whereas no difference was found in the plasma PAF-AH mass and activity as well as in the HDL-PAF-AH activity between the 2 studied subgroups. The same phenomenon was observed for serum PON1 activities. In a multivariate analysis, only the age was significantly correlated with IMT values (p<0.05). Neither the total plasma PAF-AH mass and activity nor the HDL-PAF-AH activity are associated with early carotid atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16079929     DOI: 10.1177/000331970505600413

Source DB:  PubMed          Journal:  Angiology        ISSN: 0003-3197            Impact factor:   3.619


  11 in total

1.  Lipoprotein-associated phospholipase A2 and risk of incident cardiovascular disease in a multi-ethnic cohort: The multi ethnic study of atherosclerosis.

Authors:  Parveen K Garg; Robyn L McClelland; Nancy S Jenny; Michael H Criqui; Philip Greenland; Robert S Rosenson; David S Siscovick; Neal Jorgensen; Mary Cushman
Journal:  Atherosclerosis       Date:  2015-05-16       Impact factor: 5.162

Review 2.  Lipoprotein-associated phospholipase A2: pathogenic mechanisms and clinical utility for predicting cardiovascular events.

Authors:  Vijay Nambi; Christie M Ballantyne
Journal:  Curr Atheroscler Rep       Date:  2006-09       Impact factor: 5.113

3.  Lipoprotein-associated phospholipase A2 and carotid intima-media thickness in individuals classified as low-risk according to Framingham.

Authors:  Trent A Hargens; Philip G Rhodes; Jessica VanReenen; Leonard A Kaminsky
Journal:  Cardiovasc Diagn Ther       Date:  2014-12

4.  Association of carotid plaque Lp-PLA(2) with macrophages and Chlamydia pneumoniae infection among patients at risk for stroke.

Authors:  Berna Atik; S Claiborne Johnston; Deborah Dean
Journal:  PLoS One       Date:  2010-06-09       Impact factor: 3.240

5.  The assessment of carotid intima media thickness and serum paraoxonase-1 activity in Helicobacter pylori positive subjects.

Authors:  Halide S Akbas; Sebahat Basyigit; Inci Suleymanlar; Didem Kemaloglu; Serkan Koc; Fatih Davran; Ibrahim Demir; Gultekin Suleymanlar
Journal:  Lipids Health Dis       Date:  2010-08-30       Impact factor: 3.876

6.  Serum Paraoxonase Levels are Correlated with Impaired Aortic Functions in Patients with Chronic Kidney Disease.

Authors:  Tolga H Efe; Ahmet G Ertem; Alpaslan Altunoglu; Cemal Koseoglu; Ali Erayman; Murat Bilgin; Özge Kurmuş; Turgay Aslan; Mehmet Bilge
Journal:  Acta Cardiol Sin       Date:  2016-01       Impact factor: 2.672

Review 7.  Predicting the risk of cardiovascular disease: where does lipoprotein-associated phospholipase A(2) fit in?

Authors:  Natalie Khuseyinova; Wolfgang Koenig
Journal:  Mol Diagn Ther       Date:  2007       Impact factor: 4.074

8.  Plasma lipoprotein-associated phospholipase A2 in patients with metabolic syndrome and carotid atherosclerosis.

Authors:  Hui-Ping Gong; Yi-Meng Du; Li-Na Zhong; Zhao-Qiang Dong; Xin Wang; Yong-Jun Mao; Qing-Hua Lu
Journal:  Lipids Health Dis       Date:  2011-01-19       Impact factor: 3.876

9.  The use of carotid artery ultrasonography in different clinical conditions.

Authors:  Armen Yuri Gasparyan
Journal:  Open Cardiovasc Med J       Date:  2009-07-07

10.  Is Lipoprotein-Associated Phospholipase A2 a Link between Inflammation and Subclinical Atherosclerosis in Rheumatoid Arthritis?

Authors:  Anna Södergren; Kjell Karp; Christine Bengtsson; Bozena Möller; Solbritt Rantapää-Dahlqvist; Solveig Wållberg-Jonsson
Journal:  Biomed Res Int       Date:  2015-10-04       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.